Tagged with P

France Jean-Marc Grognet, general manager of Genopole, France’s leading biotechnology cluster, explains the organization’s unique triangular structure with the corner points of the cluster being higher education, research, and industry. Grognet goes on to elaborate on the cluster’s extensive scientific offering and his ambitions to build a collaborative network of life…

Korea The Pharmaceutical Strategy Institute (PSI) is a Korean consulting firm helping local biotech companies reach success by providing strategic and legal counsel all along the value chain. Its founder & CEO, Dr Jung Yun–Taek, explains the different services his company provides, his role in shaping government policies to foster the…

Korea James Jungkue Lee, founder and CEO of Bridge Biotherapeutics, explains his strategy for risk mitigation in running a virtual biotech start-up. He also offers his insights into the company’s partnership strategy and shares his opinion on why Korea will become a global leader in biotech.   Biotech is a very…

Egypt Mohamed Swilam, country manager of Roche Egypt, explains how ensuring access to medicine in Egypt is not only related to pricing challenges, but also to support healthcare systems, improve diagnosis, educate and build local skills. He also gives insights into the company’s plans on how to partner with stakeholders across…

Opinion Rhenu Buller, an expert on disruptive technologies at business consultancy Frost & Sullivan’s Asia Pacific office, outlines the technological innovations currently driving the drug development pipelines of rare disease companies.   Recent advancements in the development of novel platforms for precise targeting of small molecules, gene therapy, stem cell therapy,…

Korea Dr Jin Hyoung Kang, president of the Cancer Study Group comments on the scope for oncology drug development in Korea, and the issues resulting from the structure of Korea’s healthcare system. Dr Kang also offers his foresight in relation to the greater role AI and big data will play within…

Egypt Ahmed Mostafa, country manager of Amgen in Egypt and Iran, explains how the affiliate has been growing by providing end-to-end solutions. He also gives his take on the Egyptian government’s prioritization of healthcare and highlights that there are still improvements needed for bringing biosimilars to Egypt.     How would…

Egypt Dr Osama Rostom, deputy head of the Pharmaceutical Chamber of the Federation of Egyptian Industries (FEI), explains how the Egyptian healthcare ecosystem has improved during the last three years thanks to an intensive collaboration between the private and public side. He also provides solutions for accelerating pharma exports from Egypt…

Korea Jong-Gu Chung, general manager of CooperVision Korea, lifts the lid on his strategy to establish their position in the Korean market for contact lenses. Chung also gives his assessment of the impact price-driven competition for lenses is having on the market, both for providers and users, and offers his ambition…

France Jaques Chevallet, CEO of Arkopharma, a European leader in herbal medicines and dietary supplements, discusses the company’s development over recent years while sharing his assessment on the current condition of the natural health product market and the role it can play as a partner to preventative care and healthcare sustainability.…

Opinion Meghann Chilcott, Chief Technology/Marketing Officer at Benzer Pharmacy charts out new pathways for improving the customer experience and sustaining business success through data-driven decision-making in support of independent pharmacists.   Patients of all ages are showing a greater desire for instant-access to healthcare information—something the digital transformation has made possible…

Opinion Jan Hux, the president and CEO of Diabetes Canada calls for governments to place greater importance on partnerships with patient groups for the making of big decisions in healthcare.    The establishment of a multi-stakeholder group, including patient organizations and patient representatives, could provide feedback and public policy recommendations to…